Effects of a continuous rate infusion of butorphanol in isoflurane-anesthetized horses on cardiorespiratory parameters, recovery quality, gastrointestinal motility and serum cortisol concentrations.

The research article investigates the impact of a continuous infusion of butorphanol on various health parameters in isoflurane-anesthetized horses.

Research Context and Methodology

• This study was designed to analyze the impacts of a continuous dose infusion (CDI) of butorphanol on cardiorespiratory parameters, recovery quality, gut motility, and blood cortisol levels in horses anesthetized with isoflurane. The subject of the study involved twelve adult male non-neutered horses who were chosen for an orchiectomy procedure.
• The horses received xylazine as a pre-anesthetic medication, and anesthesia was initiated with midazolam and ketamine and sustained using isoflurane. The horses were given either a bolus of butorphanol or an identical volume of saline solution via intravenous administration, followed by a continuous rate infusion of either butorphanol or saline.
• The animals’ cardiorespiratory performance was recorded at the outset (T0) and every 15 minutes for the next 75 minutes, beginning with the infusion. Cortisol serum concentration was also measured at the start (T0), 60 minutes in, and 30 minutes and 19 hours after the horses regained consciousness from anesthesia.
• The quality of the horses’ recovery from anesthesia was assessed using a scoring system, and gut activity was evaluated both prior to anesthesia and for a duration of 24 hours post recovery.

Research Findings

• The study found no significant variations between groups concerning cardiopulmonary parameters, serum cortisol levels, or recovery scores. There was however a noted decrease in gut mobility for 60 minutes in the butorphanol administered group (BG).

Conclusion

• The study concluded that administering a continuous infusion of butorphanol in horses anesthetized with isoflurane does not detrimentally influence the monitored cardiopulmonary parameters or recovery scores. However, a minor but statistically significant decline in gut mobility was observed in the group received butorphanol. This finding is crucial since it adds to the understanding of how anesthetics and supplementary medications may affect patient recovery and normal body functions in veterinary practice.